Job Title: Global Development Associate Medical Director

Introduction to role:

This role is based in Barcelona, with an on-site commitment of three days a week. Fluency in English is required.

Are you ready to put your medical oncology training to work at the heart of hemato-oncology development, where every decision you make strengthens patient safety and accelerates innovative trials? Do you thrive at the intersection of patient safety, trial strategy, and cross-functional leadership? In this role, you will be a key medical voice guiding global studies from early design through closeout, ensuring robust risk-benefit oversight and scientific rigor.

You will partner closely with Clinical Operations and cross-functional experts to shape protocols, engage investigators and external experts, and translate emerging data into decisive actions that keep studies on track and patients safe. You will also have the opportunity to lead process improvements and contribute to cross-asset, cross-indication initiatives—broadening your impact as our oncology portfolio advances across multiple indications and stages. Your work will directly influence how we identify patients earlier, execute trials faster, and bring transformative therapies to those who need them most.

Accountabilities:

• Responsible for ensuring the risk-benefit of a clinical study, maintaining the highest ethical and safety standards in compliance with FDA, EMEA, ICH, and GCP guidelines as well as AZ SOPs regarding safety.

• Work cross-functionally in the design and implementation of clinical hemato-oncology projects as a member of the Clinical Sub-Team (CST), ensuring scientific and clinical rigor.

• Contribute to the development of program strategy for assigned compounds/programs and collaborate with team members to develop compelling business cases for governance approval.

• Provide clinical input to influence study design through collaboration with primary investigators, key external experts (KEE), study sites, team members, and internal stakeholders.

• Participate or lead the review and assessment of new opportunities and ESRs as needed.

• Support interactions with global medical affairs, marketing companies, and commercial teams to ensure cross-functional input into protocols.

• Respond timely to investigational study sites for local ICF changes, protocol & EC/IRB questions/requests. Contribute to investigator and monitor training.

• Support the development of clinical components of regulatory and EC/IRB submission documents for marketing approval.

• Prepare clinical development plans integrating pre-clinical and early clinical findings while ensuring cross-functional alignment throughout early clinical development phases.

• Present and defend protocols and clinical development plans at internal governance forums.

• Serve as Medical Monitor, responsible for safety monitoring of clinical trials and as a medical expert for Phase I/II or Phase III studies.

• Prepare various official and regulatory documents for agencies such as Dossiers, BLAs, INDs, Safety and Annual reports.

• Implement clinical R&D policies, SOPs, and related directives.

• Contribute to Department/Clinical initiatives to improve the quality and content of all clinical programs.

Essential Skills/Experience:

• MD or international equivalent is required.

• Medical oncology clinical training is required.

Desirable Skills/Experience:

• Clinical or research experience (in an academic, pharmaceutical or CRO environment) related to the design and/or conduct of clinical studies in oncology and/or malignant hematology is preferred.

• Possesses general knowledge of Good Clinical Practice (GCP) and other regulations governing clinical research.

• Possesses general knowledge of medical monitoring, regulatory approval processes in relevant countries, pharmaceutical industry/R&D operations, marketing, and commercial fundamentals.

• Good understanding of clinical trials methodology.

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

Why AstraZeneca: Here, oncology leaders come together with data scientists, clinical operators, and external academic partners to turn bold ideas into studies that move fast and put patients first. With a broad, dynamic pipeline of novel molecules across multiple indications, you will influence programs at every stage—from shaping first-in-human protocols to driving pivotal trials—supported by strong investment, modern platforms, and a culture that values curiosity and kindness alongside ambitious goals. We bring uncommon combinations of experts into the same room to solve hard problems, learn quickly, and push for earlier detection and intervention, all with the shared aim of transforming outcomes and ultimately making cancer a less deadly disease.

Call to Action: Take the lead in advancing hemato-oncology—submit your application today and help turn rigorous science into life-changing medicines.

Date Posted

08-sept-2026

Closing Date

21-sept-2026

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.